Current status of sentinel lymph node biopsy in solid malignancies

World Journal of Surgical Oncology

Robert E Mansel¹  Amit Goyal¹ 

[1] Department of Surgery, University of Wales College of Medicine, Cardiff, United Kingdom

关键词: randomised trials;    colon cancer;    breast cancer;    melanoma;    lymphatic mapping;    Sentinel node biopsy;   

Others  :  1207482
DOI  :  10.1186/1477-7819-2-9

 received in 2004-03-21, accepted in 2004-04-24,  发布年份 2004

【 摘 要 】

Lymphatic mapping and sentinel lymph node biopsy were first reported in 1977 by Cabanas for penile cancer. Since that time, the technique has become rapidly assimilated into clinical practice. The sentinel node concept has been validated in cutaneous melanoma and breast cancer. However, follow-up data of patients from randomised trials is needed to establish the clinical significance of sentinel lymph node biopsy before accepting the procedure as a standard of care. This technique has the potential to be utilised in all solid tumours like colon, gastric, oesophageal, lung, gynaecologic, and head and neck cancer. This paper reviews the current status of sentinel lymph node biopsy in solid tumours.

【 授权许可】

   
2004 Goyal and Mansel; licensee BioMed Central Ltd. This is an Open Access article: verbatim copying and redistribution of this article are permitted in all media for any purpose, provided this notice is preserved along with the article's original URL.

【 参考文献 】

• [1]Cabanas RM: An approach for the treatment of penile carcinoma. Cancer 1977, 39:456-466.
• [2]Morton DL, Wen DR, Wong JH, Economou JS, Cagle LA, Storm FK, Foshag LJ, Cochran AJ: Technical details of intraoperative lymphatic mapping for early stage melanoma. Arch Surg 1992, 127:392-399.
• [3]Alex JC, Krag DN: Gamma-probe guided localization of lymph nodes. Surg Oncol 1993, 2:137-143.
• [4]Balch CM, Soong SJ, Bartolucci AA, Urist MM, Karakousis CP, Smith TJ, Temple WJ, Ross MI, Jewell WR, Mihm MC, Barnhill RL, Wanebo HJ: Efficacy of an elective regional lymph node dissection of 1 to 4 mm thick melanomas for patients 60 years of age and younger. Ann Surg 1996, 224:255-263.
• [5]Sim FH, Taylor WF, Ivins JC, Pritchard DJ, Soule EH: A prospective randomised study of the efficacy of routine elective lymphadenectomy in management of malignant melanoma. Preliminary results. Cancer 1978, 41:948-956.
• [6]Veronesi U, Adamus J, Bandiera DC, Brennhovd IO, Caceres E, Cascinelli N, Claudio F, Ikonopisov RL, Javorskj VV, Kirov S, Kulakowski A, Lacoub J, Lejeune F, Mechl Z, Morabito A, Rode I, Sergeev S, van Slooten E, Szcygiel K, Trapeznikov NN: Inefficacy of immediate node dissection in stage 1 melanoma of the limbs. N Engl J Med 1977, 297:627-630.
• [7]Uren RF, Howman-Giles R, Thompson JF, Shaw HM, Quinn MJ, O'Brien CJ, McCarthy WH: Lymphoscintigraphy to identify sentinel lymph nodes in patients with melanoma. Melanoma Res 1994, 4:395-399.
• [8]Godellas CV, Berman CG, Lyman G, Cruse CW, Rapaport D, Heller R, Wang X, Glass F, Fenske N, Messina J: The identification and mapping of melanoma regional nodal metastases: minimally invasive surgery for the diagnosis of nodal metastases. Am Surg 1995, 61:97-101.
• [9]Kamath D, Rapaport D, DeConti R, Cruse CW, Wells K, Glass F, Messina J, Fenske N, Brobeil A, Berman C, Puleo C, Reintgen D: Redefining cutaneous lymphatic flow: the necessity of preoperative lymphoscintigraphy in the management of malignant melanoma. J Fla Med Assoc 1997, 84:182-187.
• [10]Uren RF, Howman-Giles RB, Shaw HM, Thompson JF, McCarthy WH: Lymphoscintigraphy in high-risk melanoma of the trunk: predicting draining node groups, defining lymphatic channels and locating the sentinel node. J Nucl Med 1993, 34:1435-1440.
• [11]Albertini JJ, Cruse CW, Rapaport D, Wells K, Ross M, DeConti R, Berman CG, Jared K, Messina J, Lyman G, Glass F, Fenske N, Reintgen DS: Intraoperative radio-lympho-scintigraphy improves sentinel lymph node identification for patients with melanoma. Ann Surg 1996, 223:217-224.
• [12]Krag DN, Meijer SJ, Weaver DL, Loggie BW, Harlow SP, Tanabe KK, Laughlin EH, Alex JC: Minimal-access surgery for staging of malignant melanoma. Arch Surg 1995, 130:654-658.
• [13]Leong SP: The role of sentinel lymph nodes in malignant melanoma. Surg Clin North Am 2000, 80:1741-1757.
• [14]Morton DL, Thompson JF, Essner R, Elashoff R, Stern SL, Nieweg OE, Roses DF, Karakousis CP, Mozzillo N, Reintgen D, Wang HJ, Glass EC, Cochran AJ: Validation of the accuracy of intraoperative lymphatic mapping and sentinel lymphadenectomy for early-stage melanoma: a multicenter trial. Multicenter Selective Lymphadenectomy Trial Group. Ann Surg 1999, 230:453-463.
• [15]McMasters KM: The Sunbelt Melanoma Trial. Ann Surg Oncol 2001, 8:41S-43S.
• [16]Tanis PJ, Boom RP, Koops HS, Faneyte IF, Peterse JL, Nieweg OE, Rutgers EJ, Tiebosch AT, Kroon BB: Frozen section investigation of the sentinel node in malignant melanoma and breast cancer. Ann Surg Oncol 2001, 8:222-226.
• [17]Cochran AJ: The pathologist's role in sentinel lymph node evaluation. Semin Nucl Med 2000, 30:11-17.
• [18]Warmuth MA, Bowen G, Prosnitz LR, Chu L, Broadwater G, Peterson B, Leight G, Winer EP: Complications of axillary lymph node dissection for carcinoma of the breast: a report based on a patient survey. Cancer 1998, 83:1362-1368.
• [19]Velanovich V, Szymanski W: Quality of life of breast cancer patients with lymphedema. Am J Surg 1999, 177:184-187.
• [20]Roses DF, Brooks AD, Harris MN, Shapiro RL, Mitnick J: Complications of level I and II axillary dissection in the treatment of carcinoma of the breast. Ann Surg 1999, 230:194-201.
• [21]Hack TF, Cohen L, Katz J, Robson LS, Goss P: Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 1999, 17:143-149.
• [22]Veronesi U, Paganelli G, Viale G, Luini A, Zurrida S, Galimberti V, Intra M, Veronesi P, Robertson C, Maisonneuve P, Renne G, De Cicco C, De Lucia F, Gennari R: A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med 2003, 349:546-553.
• [23]Mansel RE, Goyal A: European studies on breast lymphatic mapping. Semin Oncol 2004, in press.
• [24]National Cancer Institute clinical trials database [http://www/nci.nci.gov/clinicaltrials/] webcite Accessibility verified April 2, 2004
• [25]McMasters KM, Wong SL, Chao C, Woo C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, Edwards MJ: Defining the optimal surgeon experience for breast cancer sentinel lymph node biopsy: a model for implementation of new surgical techniques. Ann Surg 2001, 234:292-299.
• [26]Clarke D, Newcombe RG, Mansel RE, ALMANAC Trialists Group: The learning curve in sentinel node biopsy: The ALMANAC experience. Ann Surg Oncol 2004, 11(2 Suppl):2115-2155.
• [27]Krag D, Weaver D, Ashikaga T, Moffat F, Klimberg VS, Shriver C, Feldman S, Kusminsky R, Gadd M, Kuhn J, Harlow S, Beitsch P: The sentinel node in breast cancer – a multicenter validation study. N Engl J Med 1998, 339:941-946.
• [28]Tafra L, Lannin DR, Swanson MS, Van Eyk JJ, Verbanac KM, Chua AN, Ng PC, Edwards MS, Halliday BE, Henry CA, Sommers LM, Carman CM, Molin MR, Yurko JE, Perry RR, Williams R: Multicenter trial of sentinel node biopsy for breast cancer using both technetium sulfur colloid and isosulfan blue dye. Ann Surg 2001, 233:51-59.
• [29]Tafra L, McMasters KM, Whitworth P, Edwards MJ: Credentialing issues with sentinel lymph node staging for breast cancer. Am J Surg 2000, 180:268-273.
• [30]Simmons RM: Review of sentinel lymph node credentialing: how many cases are enough? J Am Coll Surg 2001, 193:206-209.
• [31]Morrow M, Rademaker AW, Bethke KP, Talamonti MS, Dawes LG, Clauson J, Hansen N: Learning sentinel node biopsy: results of a prospective randomized trial of two techniques. Surgery 1999, 126:714-720.
• [32]Tanis PJ, Nieweg OE, Hart AA, Kroon BB: The illusion of the learning phase for lymphatic mapping. Ann Surg Oncol 2002, 9:142-147.
• [33]Goyal A, Newcombe RG, Mansel RE: Relative value of blue dye and isotope in sentinel node localization for breast cancer in a multicentre trial [abstract]. Eur J Cancer 2004, 2(suppl 3):78-79.
• [34]McMasters KM, Wong SL, Martin RC, Chao C, Tuttle TM, Noyes RD, Carlson DJ, Laidley AL, McGlothin TQ, Ley PB, Brown CM, Glaser RL, Pennington RE, Turk PS, Simpson D, Cerrito PB, Edwards MJ: Dermal injection of radioactive colloid is superior to peritumoral injection for breast cancer sentinel lymph node biopsy: results of a multiinstitutional study. Ann Surg 2001, 233:676-687.
• [35]Kern KA: Lymphoscintigraphic anatomy of sentinel lymphatic channels after subareolar injection of Technetium 99m sulfur colloid. J Am Coll Surg 2001, 193:601-608.
• [36]Mansel RE, Goyal A, Newcombe RG: Internal mammary node drainage and its role in sentinel node biopsies: the initial ALMANAC experience. Clin Breast Cancer 2004, in press.
• [37]The UK NHS Breast Screening Programme 2001/2 statistics [http://www.cancerscreening.nhs.uk/breastscreen] webcite Accessibility verified April 2, 2004
• [38]Gandy CP, Biddlestone LR, Roe AM, O'Leary DP: Intra-operative injection of Patent Blue V dye to facilitate nodal staging in colorectal cancer. Colorectal Dis 2002, 4:447-449.
• [39]Bendavid Y, Latulippe JF, Younan RJ, Leclerc YE, Dube S, Heyen F, Morin M, Girard R, Bastien E, Ferreira J, Cerino M, Dube P: Phase I study on sentinel lymph node mapping in colon cancer: a preliminary report. J Surg Oncol 2002, 79:81-84.
• [40]Feig BW, Curley S, Lucci A, Hunt KK, Vauthey JN, Mansfield PF, Cleary K, Hamilton S, Ellis V, Brame M, Berger DH: A caution regarding lymphatic mapping in patients with colon cancer. Am J Surg 2001, 182:707-712.
• [41]Esser S, Reilly WT, Riley LB, Eyvazzadeh C, Arcona S: The role of sentinel lymph node mapping in staging of colon and rectal cancer. Dis Colon Rectum 2001, 44:850-854.
• [42]Paramo JC, Summerall J, Wilson C, Cabral A, Willis I, Wodnicki H, Poppiti R, Mesko TW: Intraoperative sentinel lymph node mapping in patients with colon cancer. Am J Surg 2001, 182:40-43.
• [43]Waters GS, Geisinger KR, Garske DD, Loggie BW, Levine EA: Sentinel lymph node mapping for carcinoma of the colon: a pilot study. Am Surg 2000, 66:943-945.
• [44]Joosten JJ, Strobbe LJ, Wauters CA, Pruszczynski M, Wobbes T, Ruers TJ: Intraoperative lymphatic mapping and the sentinel node concept in colorectal carcinoma. Br J Surg 1999, 86:482-486.
• [45]Cserni G, Vajda K, Tarjan M, Bori R, Svebis M, Baltas B: Nodal staging of colorectal carcinomas from quantitative and qualitative aspects. Can lymphatic mapping help staging? Pathol Oncol Res 1999, 5:291-296.
• [46]Merrie AE, van Rij AM, Phillips LV, Rossaak JI, Yun K, Mccall JL: Diagnostic use of the sentinel node in colon cancer. Dis Colon Rectum 2001, 44:410-417.
• [47]Saha S, Bilchik A, Wiese D, Espinosa M, Badin J, Ganatra BK, Desai D, Kaushal S, Singh T, Arora M: Ultrastaging of colorectal cancer by sentinel lymph node mapping technique – a multicenter trial. Ann Surg Oncol 2001, 8:94S-98S.
• [48]Paramo JC, Summerall J, Poppiti R, Mesko TW: Validation of sentinel node mapping in patients with colon cancer. Ann Surg Oncol 2002, 9:550-554.
• [49]Bilchik AJ, Nora D, Tollenaar RA, van de Velde CJ, Wood T, Turner R, Morton DL, Hoon DS: Ultrastaging of early colon cancer using lymphatic mapping and molecular analysis. Eur J Cancer 2002, 38:977-985.